Thomas P Chapman

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Patients With Inflammatory Bowel Disease

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alex Adams, Vipin Gupta, Waled Mohsen, Thomas P Chapman, Deloshaan Subhaharan, Pradeep Kakkadasam Ramaswamy, Sudheer Kumar Vuyyuru, Saurabh Kedia, Colleen Gc McGregor, Alison Simmons, Bruce D George, Rebecca Palmer, Oliver Brain, Alissa Walsh, Vineet Ahuja, Simon P L Travis, Jack Satsangi
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response. Gut (2022)
Thomas P Chapman, Catarina Geraldes de Frias Gomes, Edouard Louis, Jean-Frédéric Colombel, Jack Satsangi
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel disease. Alimentary pharmacology & therapeutics 52 (1) (2020)
Thomas P Chapman, Catarina Geraldes de Frias Gomes, Edouard Louis, Jean Frederic Colombel, Jack Satsangi
Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics 52 (10) (2020)
Lingna Ye, Thomas P Chapman, Zhenzhen Wen, Lang Lin, Yun Qiu, Zhanju Liu, Zhihua Ran, Jiaming Qian, Kaichun Wu, Xiang Gao, Pinjin Hu, Minhu Chen, Simon P L Travis, Qian Cao, null null
Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti-TNF therapy in a tuberculosis endemic region. Alimentary pharmacology & therapeutics 53 (3) (2020)